Clinical Trials
3 trialsNCT00076401 2014-06-26
A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL)
Pharmacyclics LLC.
Phase 2 Terminated
NCT00100711 2014-05-23
Study of Motexafin Gadolinium (MGd) in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Pharmacyclics LLC.
Phase 2 Terminated
NCT00290004 2008-09-11
Study of Weekly Motexafin Gadolinium (MGd) for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Pharmacyclics LLC.
Phase 1/2 Completed